Application of adaptive optics retinal imagine (rtx1) in the early diagnosis of diabetic retinopathy

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000036090

Enrollment

Unknown

Registered

2020-08-21

Start date

2021-01-01

Completion date

Unknown

Last updated

2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic retinopathy

Interventions

Group 2:insulin

Group 1:calcium dobesilate

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria were a diagnosis of diabetes from at least 1 years and definition of no or mild signs of nonproliferative diabetic retinopathy (NPDR) according to the ETDRS severity scale,40/50 or better Uncorrected or Best Corrected Visual Acuity (UCVA or BCVA)

Exclusion criteria

Exclusion criteria: diagnosis of heavy NPDR according to the ETDRS severity scale, or the presence or a history of maculopathy or any other ocular disease, including lens opacity, or previous eye surger

Design outcomes

Primary

Measure	Time frame
visual acuty;	—

Countries

China

Contacts

Public ContactChen Zou

Eye & ENT Hospital, FudanUniversity

chenzou0814@foxmail.com+86 13524804856

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026